AstraZeneca Investors Baulk at $400 Billion Bristol Myers Talks

3-line summary

• AstraZeneca investors baulked at the company's $400 billion Bristol Myers Squibb talks, according to the report.

This summary is our own processing of the source article; see the source link below for full context.